Kissei Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3240600001
JPY
4,075.00
40 (0.99%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
97,406.00
88,330.00
75,579.00
67,493.00
65,381.00
69,044.00
63,245.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
97,406.00
88,330.00
75,579.00
67,493.00
65,381.00
69,044.00
63,245.00
Raw Material Cost
54,418.00
47,359.00
41,155.00
37,792.00
36,360.00
38,156.00
29,325.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
28.00
21.00
18.00
20.00
23.00
23.00
23.00
Selling and Distribution Expenses
23,264.00
22,179.00
20,790.00
20,304.00
19,923.00
19,607.00
21,133.00
Other Expenses
2,249.30
1,286.80
945.60
1,037.10
1,034.00
960.30
1,074.40
Total Expenditure (Excl Depreciation)
1,00,203.00
82,427.00
71,419.00
68,487.00
66,646.00
67,389.00
61,225.00
Operating Profit (PBDIT) excl Other Income
-2797
5903
4160
-994
-1265
1655
2020
Other Income
19,169.00
13,064.00
10,143.00
14,777.00
18,373.00
5,347.00
3,599.00
Operating Profit (PBDIT)
20,887.00
23,634.00
18,414.00
17,743.00
20,701.00
10,001.00
8,018.00
Interest
28.00
21.00
18.00
20.00
23.00
23.00
23.00
Exceptional Items
676.00
-3,203.00
306.00
65.00
-440.00
646.00
-803.00
Gross Profit (PBDT)
42,988.00
40,971.00
34,424.00
29,701.00
29,021.00
30,888.00
33,920.00
Depreciation
4,644.00
4,796.00
4,254.00
4,109.00
3,730.00
3,148.00
2,562.00
Profit Before Tax
16,891.00
15,610.00
14,449.00
13,680.00
16,507.00
7,476.00
4,630.00
Tax
2,930.00
3,634.00
3,159.00
3,046.00
3,475.00
2,098.00
1,741.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
13,779.00
11,961.00
11,161.00
10,529.00
12,922.00
5,285.00
2,817.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
13,779.00
11,961.00
11,161.00
10,529.00
12,922.00
5,285.00
2,817.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
181.00
14.00
128.00
105.00
110.00
93.00
71.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
13,960.00
11,975.00
11,289.00
10,634.00
13,032.00
5,378.00
2,888.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
2,30,146.00
2,09,004.00
2,20,029.00
1,93,900.00
2,01,386.00
2,19,315.00
1,92,466.00
Earnings per share (EPS)
331.53
274.2
246.58
228.3
280.19
113.25
60.3
Diluted Earnings per share
331.53
274.2
246.58
228.3
280.19
113.25
60.3
Operating Profit Margin (Excl OI)
-3.0%
6.54%
5.31%
-1.69%
-2.14%
2.18%
2.94%
Gross Profit Margin
22.11%
23.1%
24.75%
26.36%
30.95%
15.39%
11.37%
PAT Margin
14.15%
13.54%
14.77%
15.6%
19.76%
7.65%
4.45%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 10.28% vs 16.87% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2026 is 16.58% vs 6.08% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is -83.75% vs 27.80% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 33.33% vs 16.67% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2026 has fallen from Mar 2025

Compare Annual Results Of Kissei Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
97,406.00
50,370.00
47,036.00
93.38%
Other Operating Income
0.00
0.00
0.00
Total Operating income
97,406.00
50,370.00
47,036.00
93.38%
Raw Material Cost
54,418.00
18,306.00
36,112.00
197.27%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
28.00
465.00
-437.00
-93.98%
Selling and Distribution Expenses
23,264.00
28,265.00
-5,001.00
-17.69%
Other Expenses
2,249.30
21.00
2,228.30
10,610.95%
Total Expenditure (Excl Depreciation)
1,00,203.00
47,246.00
52,957.00
112.09%
Operating Profit (PBDIT) excl Other Income
-2,797.00
3,124.00
-5,921.00
-189.53%
Other Income
19,169.00
-290.00
19,459.00
6,710.00%
Operating Profit (PBDIT)
20,887.00
6,181.00
14,706.00
237.92%
Interest
28.00
465.00
-437.00
-93.98%
Exceptional Items
676.00
-479.00
1,155.00
241.13%
Gross Profit (PBDT)
42,988.00
32,064.00
10,924.00
34.07%
Depreciation
4,644.00
3,347.00
1,297.00
38.75%
Profit Before Tax
16,891.00
1,889.00
15,002.00
794.18%
Tax
2,930.00
1,363.00
1,567.00
114.97%
Provisions and contingencies
0
0
0.00
Profit After Tax
13,779.00
-805.00
14,584.00
1,811.68%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
13,779.00
-805.00
14,584.00
1,811.68%
Share in Profit of Associates
0
0
0.00
Minority Interest
181.00
1,331.00
-1,150.00
-86.40%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
13,960.00
526.00
13,434.00
2,553.99%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
2,30,146.00
30,957.00
1,99,189.00
643.44%
Earnings per share (EPS)
331.53
-5.90
337.43
5,719.15%
Diluted Earnings per share
331.53
-5.90
337.43
5,719.15%
Operating Profit Margin (Excl OI)
-3.00%
6.20%
0.00
-9.20%
Gross Profit Margin
22.11%
10.40%
0.00
11.71%
PAT Margin
14.15%
-1.60%
0.00
15.75%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 9,740.60 Million
in Mar 2026

Figures in Million
stock-summary

YoY Growth in year ended Mar 2026 is 10.28% vs 16.87% in Mar 2025

Annual - Consolidate Net Profit
Consolidate Net Profit 1,396.00 Million
in Mar 2026

Figures in Million
stock-summary

YoY Growth in year ended Mar 2026 is 16.58% vs 6.08% in Mar 2025

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 171.80 Million
in Mar 2026

Figures in Million
stock-summary

YoY Growth in year ended Mar 2026 is -83.75% vs 27.80% in Mar 2025

Annual - Interest
Interest 2.80 Million
in Mar 2026

Figures in Million
stock-summary

YoY Growth in year ended Mar 2026 is 33.33% vs 16.67% in Mar 2025

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -3.00%
in Mar 2026

Figures in %
stock-summary

YoY Growth in year ended Mar 2026 has fallen from Mar 2025